Luxempart (LXMPR) H2 2025 earnings summary

Executive summary

• Achieved strong performance in 2025, with renewed momentum and solid second-half results.

• Net Asset Value (NAV) rose 11.3% year-over-year to EUR 2,526m, with net profit reaching EUR 261m.

• Focused on private equity in the lower mid-market, deploying capital across Direct Investments in Western Europe and Investment Funds globally.

• Initiated succession process for Managing Director as part of broader governance evolution.

Financial highlights

• NAV increased by 9.3% to EUR 2,526m compared to 2024.

• Net profit for 2025 was EUR 261m, up from EUR 30.5m in 2024.

• Dividend income rose to EUR 65m from EUR 47.6m year-over-year.

• Net gains on financial assets reached EUR 211.6m, compared to EUR 0.2m in 2024.

• Proposed gross dividend of EUR 2.56 per share, a 10% increase, yielding 4.1% to year-end share price.

Outlook and guidance

• Strategic focus remains on Healthcare, Industrials, Business Services, and Financial Services.

• Plans to build a concentrated Direct Investments portfolio and expand Investment Funds exposure.

• Cautious outlook due to geopolitical tensions and technological advances, especially in AI.

• Significant liquidity position enables consideration of new acquisitions in 2026.